Related Experiment Videos
Patenting genome research tools and the law
1University of Michigan Law School, 625 S. State Street, 439 Hutchins Hal, Ann Arbor, Ml 48109, USA. rse@umich.edu
Comptes Rendus Biologies
|January 28, 2004
Summary
Gene patenting, initially uncontroversial for therapeutic proteins, became contentious with DNA sequencing. Concerns grew that gene patents, viewed as scientific information, could impede research, but stricter patent office enforcement may resolve confusion.
Area of Science:
- Biotechnology
- Intellectual Property Law
- Genomic Research
Background:
- Gene patenting for therapeutic proteins was initially uncontroversial.
- High-throughput DNA sequencing shifted gene patents towards scientific information, raising concerns.
- Evolving genomic strategies amplified worries about patent-induced research slowdowns.
Purpose of the Study:
- To analyze the evolution of gene patenting controversies.
- To examine the impact of DNA sequencing on gene patenting.
- To assess the role of patent law in genomic research.
Main Methods:
- Review of historical trends in biotechnology patenting.
- Analysis of the shift in gene patent classification.
- Examination of concerns regarding research impediments.
Main Results:
- Early gene patents for therapeutic proteins faced little controversy.
- The advent of high-throughput DNA sequencing led to gene patents being viewed as scientific information.
- Concerns emerged that gene patents could hinder subsequent scientific research.
Conclusions:
- The classification of gene patents has evolved from therapeutic products to scientific information.
- Patentability of genomic information raises complex legal and ethical questions.
- Stricter enforcement of utility and disclosure requirements may clarify patenting ambiguities.